Supernus Pharmaceuticals (SUPN) PT Raised to $45 at Jefferies, Assumes Buy
Tweet Send to a Friend
(Updated - January 3, 2023 4:54 AM EST)
Jefferies analyst Andrew Tsai raised the price target on Supernus Pharmaceuticals ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Jefferies analyst Andrew Tsai raised the price target on Supernus Pharmaceuticals ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
